CDRH Kicks Off STAMP Program With Public Forum On CSF Shunts
This article was originally published in The Gray Sheet
Executive Summary
FDA's recently initiated Systematic Technology Assessment of Medical Products (STAMP) program could be a means for the Center for Devices and Radiological Health to increase its postmarket surveillance of problematic devices that have an established commercial market.